Zoledronic acid slows down rat primary chondrosarcoma development, recurrent tumor progression after intralesional curretage and increases overall survival.

Source:http://linkedlifedata.com/resource/pubmed/id/16570273

Int. J. Cancer 2006 Sep 1 119 5 980-4

Download in:

View as

Triples

General Info

PMID
16570273